Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 6
2003 4
2004 3
2005 2
2006 5
2007 2
2008 4
2009 2
2010 5
2011 2
2012 3
2014 1
2016 1
2017 3
2018 3
2019 3
2020 1
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular delivery of drugs and biotherapeutics.
Chorny M, Levy RJ, Golomb G. Chorny M, et al. Among authors: golomb g. Drug Deliv Transl Res. 2018 Aug;8(4):865-867. doi: 10.1007/s13346-018-0483-y. Drug Deliv Transl Res. 2018. PMID: 29359245 No abstract available.
Liposomal alendronate for the treatment of restenosis.
Gutman D, Golomb G. Gutman D, et al. Among authors: golomb g. J Control Release. 2012 Jul 20;161(2):619-27. doi: 10.1016/j.jconrel.2011.11.037. Epub 2011 Dec 8. J Control Release. 2012. PMID: 22178594 Review.
Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system.
Reus P, Guthmann H, Uhlig N, Agbaria M, Issmail L, Eberlein V, Nordling-David MM, Jbara-Agbaria D, Ciesek S, Bojkova D, Cinatl J, Burger-Kentischer A, Rupp S, Zaliani A, Grunwald T, Gribbon P, Kannt A, Golomb G. Reus P, et al. Among authors: golomb g. J Control Release. 2023 Dec;364:654-671. doi: 10.1016/j.jconrel.2023.10.050. Epub 2023 Nov 16. J Control Release. 2023. PMID: 37939853 Free article.
Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes.
Hirsch S, Hinden L, Naim MB, Baraghithy S, Permyakova A, Azar S, Nasser T, Portnoy E, Agbaria M, Nemirovski A, Golomb G, Tam J. Hirsch S, et al. Among authors: golomb g. J Control Release. 2023 Jan;353:254-269. doi: 10.1016/j.jconrel.2022.11.040. Epub 2022 Nov 30. J Control Release. 2023. PMID: 36442615 Free PMC article.
Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy.
Ben-David-Naim M, Dagan A, Grad E, Aizik G, Nordling-David MM, Morss Clyne A, Granot Z, Golomb G. Ben-David-Naim M, et al. Among authors: golomb g. Cancers (Basel). 2019 Mar 29;11(4):442. doi: 10.3390/cancers11040442. Cancers (Basel). 2019. PMID: 30934857 Free PMC article.
Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity.
Biswas S, Rust LN, Wettengel JM, Yusova S, Fischer M, Carson JN, Johnson J, Wei L, Thode T, Kaadige MR, Sharma S, Agbaria M, Bimber BN, Tu T, Protzer U, Ploss A, Smedley JV, Golomb G, Sacha JB, Burwitz BJ. Biswas S, et al. Among authors: golomb g. Nat Commun. 2022 May 30;13(1):2995. doi: 10.1038/s41467-022-30593-0. Nat Commun. 2022. PMID: 35637225 Free PMC article.
Liposomal temozolomide drug delivery using convection enhanced delivery.
Nordling-David MM, Yaffe R, Guez D, Meirow H, Last D, Grad E, Salomon S, Sharabi S, Levi-Kalisman Y, Golomb G, Mardor Y. Nordling-David MM, et al. Among authors: golomb g. J Control Release. 2017 Sep 10;261:138-146. doi: 10.1016/j.jconrel.2017.06.028. Epub 2017 Jun 27. J Control Release. 2017. PMID: 28666727
51 results